Stock Analysis
Lantheus Holdings, Inc. (LNTH) Stock Analysis
Lantheus Holdings, Inc. (LNTH) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Lantheus Holdings, Inc. (LNTH) currently has an AIQ Score of 65/100, indicating a neutral setup. Quality is the strongest factor at 73/100. Value is the weakest current factor at 52/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
LNTH at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $100.46 |
| AIQ Score | 65/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Buy |
| Market Cap | $6.57B |
| P/E Ratio (TTM) | 23.96 |
| Forward P/E | — |
| EPS (quarter ended 2026-06-30) | $1.15 |
| Revenue (quarter ended 2026-06-30) | $388.18M |
| Dividend Yield (TTM) | 0.00% |
| Beta | -0.06 |
| Volume | 476.26K |
| 52-week range | $50.16-$111.86 |
| RSI 14 | 53.62 |
| 50-Day SMA | $100.25 |
| 200-Day SMA | $91.21 |
| Analyst Price Target | $109.09 |
| Next Earnings | Nov 5, 2026 |
LNTHLantheus Holdings, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
Leader
Strong Relative Position
Latest quote
- Momentum65
- Value52
- Quality73
- Risk resilience72
- Sentiment—
LNTH Stock Analysis Summary
Lantheus Holdings, Inc. (LNTH) currently has an AIQ Score of 65/100, indicating a neutral setup. Quality is the strongest factor at 73/100. Value is the weakest current factor at 52/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, LNTH has AIQ Score of 65/100 with Quality base of 73/100 and fading Value at 52/100. Wait for component alignment before adding exposure.
Quality (73/100) leads while Value (52/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · 0.14% stock move · LNTH classified in Drug Manufacturers - Specialty & Generic.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is LNTH Bullish or Bearish Right Now?
LNTH currently has a neutral overall setup. Quality is the strongest factor at 73/100, while Value is weakest at 52/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Quality is supportive at 73/100.
- - Momentum is constructive at 65/100.
- - Risk Resilience is supportive at 72/100.
- - Price is +0.07% above its 50-day SMA.
- - Analyst target implies +8.59% upside from the latest quote.
- - No strong bearish evidence is available in the current snapshot.
Current Consensus
LNTH's Technical Analysis Consensus is currently Buy, with 30 buy, 5 neutral, and 10 sell votes. LNTH's 14-day RSI is 53.62, which places the stock in a neutral momentum range. LNTH's beta is -0.06, indicating lower market sensitivity than the broad market.
What Changed in LNTH?
The largest recent change in LNTH is Momentum moving up by 14.0 points over the available 7-day comparison window. Quality remains the strongest visible factor.
What Would Change the LNTH Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
LNTH Decision Framework
Public evidence layers, setup checks, and risk context for Lantheus Holdings, Inc..
Lantheus Holdings, Inc. (LNTH) Stock Analysis
Lantheus Holdings, Inc. has an AIQ Score of 65/100 in a Neutral regime. Quality is strongest at 73/100. Beta is -0.06, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | LNTH is in a Neutral AIQ regime with score 65/100. |
| Signal Conflict | The primary conflict is that quality leads at 73/100 while value lags at 52/100. |
| Factor Evidence | Momentum 65/100 · Value 52/100 · Quality 73/100 · Risk 72/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Quality is the strongest factor at 73/100.
Momentum is 65/100 and RSI (14) is 53.6.
LNTH is in a Neutral regime at 65/100.
Risk factor is 72/100 with beta -0.06 and annual volatility 32.28%.
Current conflict: quality leads at 73/100 while value lags at 52/100.
LNTH Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
LNTH Fundamentals
LNTH valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
LNTH Technical Analysis
LNTH technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
LNTH Stock Catalysts
Track LNTH earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
LNTH Dividend Analysis
LNTH dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
LNTH Financial Data
LNTH revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
LNTH Risk Analysis
LNTH volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
LNTH Stock News
LNTH stock news, market tone, recent headlines, and catalyst context.
LNTH vs Life Sciences / Tools / CRO Peers
Current peer cohort: LNTH · MEDP · NTRA · PRGO · PTCT. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| LNTH Current stock | 65/100 | 52/100 | 65/100 | 72/100 | 1.86 | 32.28% | Current |
| MEDP Medpace Holdings | 64/100 | 27/100 | 95/100 | 56/100 | 0.48 | 43.65% | LNTH vs MEDP |
| NTRA Natera | 56/100 | 34/100 | 79/100 | 57/100 | 1.85 | 48.45% | LNTH vs NTRA |
| PRGO Perrigo | 55/100 | 74/100 | 70/100 | 51/100 | -0.3 | 56.40% | LNTH vs PRGO |
| PTCT PTC Therapeutics | 55/100 | 38/100 | 43/100 | 58/100 | 0 | 40.85% | LNTH vs PTCT |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Oct 29, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Oct 31, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching LNTH
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for LNTH
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
LNTH Stock FAQ
What is LNTH stock price today?
Lantheus Holdings, Inc.'s current stock price is $100.46. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is LNTH bullish or bearish right now?
LNTH's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is LNTH's market cap?
LNTH's market cap is $6.57B based on the latest completed market-close snapshot from Oct 30, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is LNTH's current P/E ratio?
LNTH's current P/E ratio is 23.96 based on the latest completed market-close snapshot from Oct 30, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is LNTH's RSI?
LNTH's 14-day RSI is 53.62 based on the latest completed market-close snapshot from Oct 30, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is LNTH above its 50-day and 200-day moving averages?
LNTH is 0.07% from its 50-day SMA and 9.99% from its 200-day SMA based on the latest completed market-close snapshot from Oct 30, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is LNTH's next earnings date?
LNTH's next earnings date is currently listed as Nov 5, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does LNTH pay a dividend?
LNTH's dividend yield is 0.00% based on the latest completed market-close snapshot from Oct 30, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.